Abiomed agrees to pay $3 million to settle kickbacks allegations

Share

AbiomedFederal prosecutors said today that Abiomed (NSDQ:ABMD) agreed to pony up more than $3 million to settle allegations that it wined and dined physicians to induce them to use its Impella heart pump.

The U.S. Justice Dept. said that Danvers, Mass.–based Abiomed agreed to settle the allegations for $3.1 million after a whistleblower’s lawsuit – which is still under seal at the U.S. District Court for Massachusetts – accused the company of buying meals for doctors “at some of the country’s most expensive restaurants, including Menton in Boston, Nobu in Los Angeles, Spago in Beverly Hills, and Eleven Madison Park in New York City.”

Get the full story on sister site MassDevice.

Inside Hologic's evolving definition of women's healthcare

textadimage Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.

At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!

REGISTER NOW

Use code WOMENSHEALTH to save an additional 10%.

Speak Your Mind

*